EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Securidaca inappendiculata Extract Mitigates Joint Damage in Collagen‐Induced Arthritis Rats Through Modulation of the SIRT1 / HIF ‐1α/Glycolysis Pathway

Yuyan Zhou iD, Yuyun Zhou, Ruoxuan Xiang, Xin Liu iD, Ting Wang, Xuan Chen, Guodong Wang iD

Pharmacology Research & Perspectives · 2026

DOI: 10.1002/prp2.70320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2026. Verfasst von Yuyan Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Wannan Medical College, Wuhu, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Anti-Inflammatory Agents, Arthritis, Rheumatoid, Xanthones. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, the National Undergraduate Training Program for Innovation and Entrepreneurship, the 2025 Anhui Provincial University STEM Faculty Enterprise Attachment Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Securidaca inappendiculata (SI) Hassk. is a traditional Chinese herbal medicine commonly used in Southern China for the treatment of rheumatoid arthritis (RA). However, its exact mechanism of action remains unclear. In this study, we evaluated the therapeutic effects of the SI‐derived compound 1,7‐dihydroxy‐3,4‐dimethoxyxanthone (XAN) in a collagen‐induced arthritis (CIA) rat model by measuring paw thickness, joint morphology, and histopathological changes. In vitro, cytotoxicity of XAN on RAW 264.7 macrophages was assessed using the Cell Counting Kit‐8 (CCK‐8) assay. Additional experiments, including real‐time PCR, immunofluorescence, glycolytic metabolism analysis, Western blotting, and dual‐luciferase reporter assays, were conducted to investigate the mechanisms underlying the anti‐inflammatory effects of XAN. Results showed that XAN significantly alleviated arthritis severity in CIA rats. In RAW 264.7 cells, lipopolysaccharide (LPS) enhanced glycolysis and upregulated NAMPT and HIF‐1α expression, whereas SIRT1 levels were reduced. XAN treatment reversed these effects by suppressing glycolysis in LPS‐induced macrophages, indicating that its anti‐inflammatory activity involves modulation of cellular energy metabolism. Further mechanistic studies revealed that XAN attenuates inflammation by regulating the SIRT1/HIF‐1α/glycolysis signaling axis in macrophages. These findings underscore the role of energy metabolism in macrophage polarization and suggest that targeting this pathway may represent a promising therapeutic strategy for RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalAnti-Inflammatory AgentsArthritis, RheumatoidXanthonesDrugs, Chinese HerbalPlant ExtractsAnimalsSirtuin 1Hypoxia-Inducible Factor 1, alpha SubunitRAW 264.7 CellsRatsGlycolysisMiceMaleRats, Sprague-DawleySignal TransductionNicotinamide PhosphoribosyltransferaseJointsMacrophagesCytokines

Stichwörter der Autor:innen

Chinese herbal remedySIRT1/HIF‐1α/glycolysis signalingmacrophage polarizationmetabolic reprogrammingrheumatoid arthritis

Substanzen

Sirtuin 1Hypoxia-Inducible Factor 1, alpha SubunitHif1a protein, ratSirt1 protein, ratAnti-Inflammatory AgentsNicotinamide PhosphoribosyltransferaseXanthonesDrugs, Chinese Herbalnicotinamide phosphoribosyltransferase, ratPlant Extracts

Autor:innen und Institutionen

  • Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Wannan Medical College, Wuhu, China.
  • Anhui Provincial Engineering Research Center for Polysaccharide Drugs, Wannan Medical College, Wuhu, China.
  • Anhui Provincial Engineering Laboratory for Screening and Re-Evaluation of Active Compounds of Herbal Medicines in Southern Anhui, Wannan Medical College, Wuhu, China.
  • Anhui Provincial Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China.

ORCID-Profile: Yuyan Zhou, Xin Liu, Guodong Wang

Förderung

  • Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM
  • the National Undergraduate Training Program for Innovation and Entrepreneurship
  • the 2025 Anhui Provincial University STEM Faculty Enterprise Attachment Program
  • the Biopharmaceutical Discipline Service Project for Anhui's Emerging Industries
  • the Biotechnological Pharmaceutical Production-Education Integration Course Project

Zitieren

APA

Zhou, Y., Zhou, Y., Xiang, R., Liu, X., Wang, T., Chen, X., & Wang, G. (2026). Securidaca inappendiculata Extract Mitigates Joint Damage in Collagen‐Induced Arthritis Rats Through Modulation of the SIRT1 / HIF ‐1α/Glycolysis Pathway. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70320

Vancouver

Zhou Y, Zhou Y, Xiang R, Liu X, Wang T, Chen X, et al. Securidaca inappendiculata Extract Mitigates Joint Damage in Collagen‐Induced Arthritis Rats Through Modulation of the SIRT1 / HIF ‐1α/Glycolysis Pathway. Pharmacology Research & Perspectives. 2026. doi:10.1002/prp2.70320

BibTeX
@article{Zhou2026,
  author = {Zhou, Yuyan and Zhou, Yuyun and Xiang, Ruoxuan and Liu, Xin and Wang, Ting and Chen, Xuan and Wang, Guodong},
  title = {Securidaca inappendiculata Extract Mitigates Joint Damage in Collagen‐Induced Arthritis Rats Through Modulation of the SIRT1 / HIF ‐1α/Glycolysis Pathway},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  doi = {10.1002/prp2.70320}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche